Yang and colleagues [44] investigated the effects of recombinant human brain natriuretic peptide (rhBNP) combined with tolvaptan on cardiac and renal function in patients with severe heart failure, finding improved cardiac function, reduced inflammation and better renal outcomes compared to tolvaptan alone. Here, NPPB is linked to heart failure.